NASDAQ · Biotechnology

ATYR (ATYR) Stock

$0.49 +1.19% NASDAQ: ATYR Healthcare

Valuation

MetricValue
Price$0.49
Market Cap$47.62M
P/E Ratio-0.72
P/B Ratio0.78
P/S Ratio236.92
EPS (TTM)$-0.40
52-Week High$7.29
52-Week Low$0.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-105.63%
ROA-51.79%
ROCE-116.42%
Gross Margin-117.55%
Operating Margin-385.74%
Net Margin-368.57%
Debt/Equity0.20
Current Ratio5.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$10.0M$0$0$0
Operating Profit$-34.0M$-46.0M$-55.0M$-68.0M$-78.0M
Net Profit$-34.0M$-45.0M$-50.0M$-64.0M$-74.0M
EPS$-1.77$-1.60$-0.94$-0.86$-0.80
Op Margin—-446.8%-15557.8%-28899.6%-40856.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$116.0M$96.0M$121.0M$97.0M$94.0M
Total Liabilities$6.0M$25.0M$30.0M$27.0M$27.0M
Cash$2.0M$10.0M$23.0M$11.0M$11.0M
Borrowings$1.0M$12.0M$15.0M$13.0M$12.0M

Latest News

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026 GlobeNewswire · Jul 15, 2026 What It Means To Hold Moderna Stock In A Crash Trefis · Jul 13, 2026 Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing GlobeNewswire · Jun 26, 2026 Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th GlobeNewswire · Jun 23, 2026 Atyr Pharma: Q1 Earnings Snapshot Associated Press · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-33.0M$-42.0M$-33.0M$-69.0M$-62.0M
Investing Cash Flow$-92.0M$46.0M$-24.0M$17.0M$-5.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-15.0M$11.0M$13.0M$-12.0M$-1.0M
Free Cash Flow$-33.0M$-44.0M$-37.0M$-69.0M$-62.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.16
FCF Yield-131.73%
Quick Ratio5.78
Interest Coverage—
Return 1Y-90.31%
Return 3Y-72.03%
Return 5Y-87.88%

Ownership

Insiders Held2.45%
Institutions Held46.47%
Institutions Float Held47.64%
Institutional HolderSharesReport Date
FMR, LLC14,706,8432026-03-31
Federated Hermes, Inc.10,509,6782026-03-31
Blackrock Inc.6,443,9042026-03-31
UBS Group AG3,867,2132026-03-31
Vanguard Capital Management LLC3,812,1322026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
ALXO $1.95 -2.26% -1.04 $261.72M 0.00%
CAMP $3.47 +6.12% -1.70 $73.70M 0.00%
DTIL $7.00 +1.60% -1.97 $89.80M 0.00%
HYFT $1.29 -4.44% -1.77 $60.61M 0.00%

About ATYR

ATYR is led by CEO Sanjay S. Shukla, employs 56 people, headquartered in US, publicly traded since 2015.

ATYR stock trades at $0.49 with a market capitalization of $47.62M. The stock is valued at a price-to-earnings (P/E) ratio of -0.72, price-to-book of 0.78, price-to-sales of 236.92. Over the past 52 weeks the stock has ranged between $0.40 and $7.29, and currently trades 93.3% below its 52-week high.

On profitability, ATYR generates a return on equity (ROE) of -105.63%, return on capital employed of -116.42%, an operating margin of -385.74%, a net profit margin of -368.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides